Reuters Market Eye - Shares in Jubilant Life Sciences plunge 14.2 percent to a two-week low.
The company reported a net loss of 941 million rupees in the September quarter, compared with a net loss of 805.8 million rupees posted a year ago.
Macquarie Securities cut its EPS estimates for the company to 23.6 rupees and 30.3 rupees for FY15 and FY16 from 26 rupees and 33.3 rupees.
"We believe free cash flow generation and margin recovery are quintessential for investors to regain confidence," it added.
(Reporting by Indulal PM)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app